Goldman Sachs Discount Zert TDXP .../ DE000GC7ETV2 /
| 1/20/2021 8:34:22 AM | Chg.+0.03 | Bid6:20:23 PM | Ask6:20:23 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 26.71EUR | +0.11% | 26.78 Bid Size: 5,000 |
26.80 Ask Size: 5,000 |
TECDAX | - EUR | 6/22/2022 | Call |
pressetext
12/30/2020
PTA-News: ERWE Immobilien AG: ERWE Immobilien AG advances to the Prime Standard
pressetext
9/11/2018
PTA-News: Medigene AG: Medigene participates at further conferences in September
pressetext
8/7/2018
PTA-News: Medigene AG: Medigene Reports Results for the First Half of 2018<BR/>Conference call and w...
pressetext
7/2/2018
PTA-News: Medigene AG: Medigene presents at upcoming conferences<BR/>Medigene presents at upcoming c...
pressetext
4/19/2018
PTA-News: Medigene AG: Medigene presents data on the successful production of AML DC vaccines at AAC...
pressetext
4/17/2018
PTA-News: Medigene AG: Clinical data for DC vaccine in prostate cancer IIT study presented by Oslo U...
pressetext
4/11/2018
PTA-News: Medigene AG: Medigene appoints Dr. Kai Pinkernell to the Executive Management Board as CMO...
pressetext
2/26/2018
PTA-News: Medigene AG: Medigene announces participation at four upcoming conferences
pressetext
1/19/2018
PTA-News: Medigene AG: Medigene announces participation at six upcoming investor and scientific conf...
pressetext
12/5/2017
PTA-Adhoc: Medigene AG: Medigene sells US-rights for Veregen® and raises financial guidance 2017
pressetext
12/4/2017
PTA-News: Medigene AG: Medigene announces participation at upcoming investor and scientific conferen...
pressetext
11/27/2017
PTA-News: Medigene AG: Patient recruitment completed for Phase I/II DC vaccine trial in AML